Health Problems

FDA-approved drug effectively treats rare chronic immune disorders

A drug approved to treat a severe form of asthma dramatically improved the health of people with rare chronic immune disorders called hypereosinophilic syndromes (HES) in whom other treatments were ineffective or intolerable. This finding comes from a small clinical trial led by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part […]

Health Problems

Study explaining side effects of statins finds drug can have unexpected benefits

While investigating why cholesterol-lowering drugs called statins cause negative side effects such as blurred vision, short-term memory loss or increased risk for diabetes, cellular chemists at The University of Toledo discovered several previously unknown benefits. It is well-established statins can help lower the risk of heart attack by lowering blood cholesterol, but statins also may […]

Health Problems

Using an anti-smoking drug to control neurons

An anti-smoking drug now has a new job—as a chemical switch to turn select neurons on or off. The drug latches on to designer proteins, called ion channels, that control whether or not a neuron will send a message. By putting those proteins only in certain groups of neurons, scientists can target modulation of specific […]

Health Problems

FDA approves first immunotherapy drug for breast cancer

(HealthDay)—The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) was given accelerated approval for triple-negative breast cancer that is locally advanced or has metastasized, cannot be surgically removed, and is programmed death-ligand 1-postive, CNN reported. A study published […]

Health Problems

New tuberculosis drug may shorten treatment time for patients

A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much lower tendency to develop resistance, and it remains in the tissues where the Mycobacterium tuberculosis bacteria reside for […]